VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-7.21 Cr | ₹-51 Cr | ₹-17 Cr | ₹56 Cr | ₹-4.75 Cr |
What is the latest Cash Flow from Investing Activities ratio of VENUS REMEDIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-7.21 Cr |
Mar2023 | ₹-51 Cr |
Mar2022 | ₹-17 Cr |
Mar2021 | ₹56 Cr |
Mar2020 | ₹-4.75 Cr |
How is Cash Flow from Investing Activities of VENUS REMEDIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-7.21 Cr | Negative | |
Mar2023 | ₹-51 Cr | Negative | |
Mar2022 | ₹-17 Cr | Negative | |
Mar2021 | ₹56 Cr | Positive | |
Mar2020 | ₹-4.75 Cr | - |
Compare Cash Flow from Investing Activities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹424.6 Cr | 6.5% | 2.1% | -21.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,544.0 Cr | 2.7% | -2.4% | 49.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,865.0 Cr | 2.9% | 6.2% | 64.2% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 1% | 6.4% | 28.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,224.0 Cr | 1% | -2.3% | 6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,832.3 Cr | 2.4% | -1.1% | 53.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 6.5% |
2.1% |
-21.1% |
SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses